All Stories

  1. W269 Adverse drug reactions of tacrolimus after liver transplant – Our Experience
  2. 4CPS-221 Potentially inappropriate medicines in older patients
  3. 4CPS-243 Healthcare associated Clostridioides difficile infection in surgical and medical patients
  4. Inhaler technique training of community pharmacists and common errors
  5. Impact of pharmacist’s intervention on decreasing erlotinib interactions in the treatment of lung cancer patients in low resource settings
  6. Pharmaceutical care in Alzheimer's disease
  7. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis
  8. Adverse drug reactions caused by drug–drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items
  9. A Simple Index for Nonalcoholic Steatohepatitis—HUFA—Based on Routinely Performed Blood Tests
  10. Effect of tacrolimus on serum low-density lipoprotein cholesterol levels in liver transplant patients
  11. 2SPD-002 Economic aspects of the use of fluids in sepsis
  12. Efficacy and safety of combined treatment of acute rhinosinusitis by herbal medicinal product Sinupret and mometasone furoate nasal spray
  13. CP-052 Economic aspects of the use of carbapenems in critically ill patients
  14. Beta-lactam antibiotics use in intensive care units - the pathophysiological, pharmacokinetic, pharmacodynamic and pharmacoeconomic approach
  15. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients
  16. P.5.d.003 No effect of carbamazepine daily dose on phenobarbital elimination in adult epileptic patients – population pharmacokinetic analysis
  17. Clinical pharmacokinetics in optimal gentamicin dosing regimen in neonates
  18. Potentially Inappropriate Prescribing in Older Primary Care Patients
  19. Total plasma protein effect on tacrolimus elimination in kidney transplant patients – Population pharmacokinetic approach
  20. Factors influencing antibiotic treatment cost and outcome in critically ill patients: A “real-life” study
  21. Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients—nonlinear mixed effects modelling approach
  22. CPC-066 Identification of Patient Groups with Insufficient Knowledge About Their Medicines at Hospital Discharge
  23. OHP-065 Pharmaceutical Services in Hospitals in Serbia
  24. Predictors of the use of medications before and during pregnancy
  25. Drug use before and during pregnancy in Serbia
  26. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics
  27. Population Pharmacokinetic Analysis of Therapeutic Drug Monitoring Data in Optimizing Pharmacotherapy of Antiepileptic Drugs
  28. Getting the balance right: Established and emerging therapies for major depressive disorders
  29. Methotrexate‐associated neurotoxicity is not only insufficient leucovorin rescue
  30. Methotrexate-Associated Biochemical Alterations in a Patient with Chronic Neurotoxicity
  31. Biochemical and Clinical Aspects of Methotrexate Neurotoxicity